Educational Training Influence in Patients With PAH(Pulmonary Artery Hypertension) on Inhaled Ventavis Treatment Adherence Evaluated Trough INSIGHT System

CompletedOBSERVATIONAL
Enrollment

38

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

January 31, 2013

Study Completion Date

June 30, 2014

Conditions
Pulmonary Arterial Hypertension
Interventions
OTHER

Iloprost (Ventavis inhaled, BAYQ6256)

An extra educational reinforcement at baseline and at 6 months will be given to a group of patients

OTHER

Iloprost (Ventavis inhaled, BAYQ6256)

No extra educational reinforcement.

Trial Locations (1)

Unknown

Many Locations

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Dra. Pilar Escribano Subías - Coordinator - HU 12 de Octubre - Madrid (Spain)

UNKNOWN

lead

Bayer

INDUSTRY

NCT01468545 - Educational Training Influence in Patients With PAH(Pulmonary Artery Hypertension) on Inhaled Ventavis Treatment Adherence Evaluated Trough INSIGHT System | Biotech Hunter | Biotech Hunter